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Abstract 1 
Objective: Resistance training (RT) improves walking ability in persons with peripheral 2 
artery disease. We conducted a meta-analysis of randomised controlled trials (RCTs) 3 
investigating the effect of RT on peripheral artery disease (as measured by walking ability).  4 
Design: We included RCTs that investigated the effect of RT on treadmill and/or 6-minute 5 
walk (6-MWT) distances. RT intensity was assessed according to ACSM guidelines by 1RM 6 
or Rating of Perceived Exertion (RPE). Standardised mean (SMD) and mean differences 7 
(MD) were calculated using a random effects inverse variance model. Heterogeneity and bias 8 
were assessed using Revman 5.3. Meta-regression and meta-anova were performed as 9 
moderator analyses.  10 
Data Sources: Databases (Medline, Embase, Web of Science, Cinahl, Google Scholar) were 11 
searched until July 2018.  12 
Results: Fifteen trials isolated RT; 7 trials compared RT to aerobic exercise. We analysed 13 
826 patients (n=363 completing RT), mean age 67.1±3.8 years. Training ranged from low-14 
high intensity; 2-7 times per week for 17±7weeks, with a mix of upper, lower or whole body 15 
training. Overall RT significantly improved constant load treadmill claudication onset 16 
(COD)(SMD 0.66[0.40, 0.93], p<0.00001) and total walking distance (WD)(SMD 0.51[0.23, 17 
0.79], p=0.0003), progressive treadmill COD(SMD 0.56[0.00, 1.13], p=0.05) and total 18 
WD(SMD 0.45[0.08, 0.82], p=0.02) and 6-MWT COD(MD 82.23m[40.91, 123.54], 19 
p<0.0001). Intensity played a role in improvements, with high intensity training yielding the 20 
greatest improvement (p=0.02).  21 
Conclusions: RT clinically improved treadmill and flat ground walking ability in persons 22 
with PAD. Higher intensity training was associated with better outcomes. Our study makes a 23 
case for clinicians to include high intensity lower body RT in treatment of peripheral artery 24 
disease.  25 
PROSPERO Systematic Review Registration #: CRD42017081184 26 
 27 
 28 
 29 
Summary Points: What is already known? 
• Interval walking is the current gold standard treatment for PAD.  
• Resistance training can improve walking ability in persons with peripheral artery disease; there 
has been no previous synthesis of the literature. 
What are the new findings? 
• Resistance training improves both flat ground and graded treadmill walking ability in persons 
with peripheral artery disease, by a clinically meaningful extent. 
• Better results were related to higher intensity training. 
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 1 
Introduction 2 
Peripheral artery disease (PAD) is an atherosclerotic disease affecting the arteries of the 3 
periphery, most commonly the aorta and iliac arteries, and the arteries of the lower limbs and 4 
it affects over 200 million people worldwide(1). Although some people may be 5 
asymptomatic, others may present with intermittent claudication symptoms. Claudication,  a 6 
fatigue, cramp, discomfort or pain in the lower limb, is a symptom of reduced muscle blood 7 
supply(2). Peripheral artery disease eventually denervates lower limb muscle fibres(3), which 8 
causes muscle weakness,(4, 5) atrophy(6, 7) and altered lower limb biomechanics(8-10). This 9 
limits walking ability and impairs quality of life in this population.   10 
 11 
Current treatment guidelines for peripheral artery disease (PAD) recommend interval walking 12 
as the first line therapy, along with other modes of aerobic exercise and resistance training 13 
(RT) as an adjunct treatment for the condition(2, 11). In addition, some guidelines omit the 14 
mode of exercise and only provide prescriptive elements of supervision, frequency, duration 15 
and length of program(12). Whilst intermittent walking is an effective exercise prescription 16 
for people who can complete it, people with severe intermittent claudication may struggle to 17 
take part due to chronic diseases and conditions that limit the ability to walk or be physically 18 
active (e.g. chronic obstructive pulmonary disease, obesity, arthritis, amputation or 19 
cerebrovascular disease with stroke(13)).  Furthermore, people with intermittent claudication 20 
have intense pain with walking(14, 15). Some people have low confidence in their walking 21 
ability, and believe the pain induced by it can be harmful(14, 16). These factors might lead to 22 
increased sedentary behaviour(17), accelerated functional decline(18), reduced aerobic 23 
capacity or cardiorespiratory fitness and reduced muscle strength and endurance (19-22), all 24 
impairing walking ability further and ultimately reducing quality of life(23).  25 
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 1 
RT does not typically cause claudication pain(24-28), and improves cardiovascular disease 2 
risk factors(29-35) and aerobic capacity and attenuates functional decline, yet is typically 3 
recommended only as an adjunct to aerobic exercise for the treatment of PAD(2, 36).   4 
Therefore, we conducted a systematic review and meta-analysis on randomised controlled 5 
trials (RCTs) using RT as an intervention for persons with PAD, with walking ability as an 6 
outcome. We aimed to identify whether or not RT is effective at improving walking ability in 7 
this population by analysing the effect of RT compared to usual care or aerobic exercise 8 
training on six minute walk (6-MWT) distance and treadmill walking. Primary outcomes 9 
included claudication onset distance (COD) and total walking distance (WD) for all walking 10 
tests. We also aimed to identify whether there are any moderators associated with changes in 11 
walking ability.  For the purpose of this review, RT included any structured body weight, 12 
machine and/or free weight-based RT where muscles contracted against some form of 13 
external resistance or immovable object/surface.   14 
 15 
Methods 16 
This review was registered with PROSPERO on the 8th December 2017 CRD42017081184 17 
Five electronic databases (Ovid Medline/PubMed, Scopus/Web of Science, PEDro, 18 
EMBASE and Cochrane Library) were searched from earliest record until July 2018. Search 19 
terms used include (peripheral vascular or claudica* or peripheral arter*) AND (exer* or 20 
resist* or weightlifting or strength or musc* exercise or circuit or endurance) AND (random* 21 
or control*). One study author (BP) ran the search and uploaded the search results into one 22 
Endnote database. After excluding duplicates one author (BP) reviewed all titles and abstracts 23 
for possible inclusion. Any full papers that were retrieved for evaluation were then screened 24 
by two authors for inclusion (BP and YM). Any disputes were settled by a third author 25 
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(MFS).  The reference lists of eligible papers were reviewed to identify other relevant studies 1 
and recent related systematic reviews were consulted to identify any additional studies that 2 
may have been missed. 3 
 4 
Studies were included if they were a randomised controlled trial on any persons with 5 
diagnosed PAD who took part in a RT intervention for ≥4 weeks, with walking ability 6 
measured via treadmill protocols and/or the six minute walk test (6-MWT) distance as an 7 
outcome. For the purpose of this review, muscular fitness was defined according to the 8 
American College of Sports Medicine (ACSM) where it is used as a collective term for 9 
muscular strength, power and endurance(37). Muscular fitness can be improved by a strength 10 
exercise training program, where a movement is performed that causes the muscles to 11 
contract against an external resistance with the expectation of increases in strength, tone, 12 
mass and/or endurance(38). Equipment used can include free weights, machines with stacked 13 
weights, pneumatic resistance, resistance bands, springs or body weight. To be included in 14 
this review RT must have included multi-joint or compound exercises (e.g., chest press, 15 
shoulder press, pull downs, rows, leg press, squats, deadlifts), or single joint exercises 16 
targeting major muscle groups (e.g., bicep curls, triceps extensions, quadriceps extensions, 17 
leg curls, calf raises). Studies that included exercises targeting the core muscles (e.g., planks, 18 
bridges) were also included. Training programs could be circuit type in nature, where clear 19 
exercise:rest intervals were defined, or a more traditional form of RT where reps and sets 20 
were completed without specified set time and recovery between sets was 2-3 minutes. To be 21 
labelled progressive, the resistance exercise must have been progressive by design, in that the 22 
absolute workload prescribed increased over time(38). The workload increase may have been 23 
achieved by greater forces used, number of exercises, volumes (sets/reps), frequencies of 24 
training, or relative intensities of the loads or maximal effort prescribed. 25 
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 1 
As there is a dose-response association between the volume of exercise and some 2 
outcomes(38), RT volume was defined using sets x repetitions x number of days per 3 
week(37). Intensity was also defined according to ACSM(39) where: 4 
• ≥85% of 1 repetition maximum (1RM) or Rate of Perceived Exertion(40) (RPE) ≥18 5 
is very high, near maximal or maximal; 6 
• 70-84% of 1 RM or RPE 14-17 is high; 7 
• 50-69% of 1 RM or RPE 12-13 is moderate; 8 
• 30-49% 1RM or RPE 9-11 is light; 9 
• <30% 1RM or RPE<9 is very light. 10 
 11 
To be included studies must have compared the intervention to the current unsupervised 12 
walking guidelines (usual medical care), or a supervised aerobic exercise training program. 13 
Outcomes to be assessed included COD, defined as the moment in which claudication pain 14 
starts, and total WD, defined as the maximal walking distance obtained from a constant load 15 
and/or graded treadmill test and/or 6-MWT. A secondary outcome of muscle strength was 16 
assessed for trials that included this measure. Trials were excluded if they combined a RT 17 
intervention with an aerobic exercise intervention and the effects of RT could not be isolated; 18 
or if they were completed on animals, or not published in English in a peer-reviewed journal 19 
or thesis. Trials were also excluded if asymptomatic patients were grouped with symptomatic 20 
patients with PAD and the symptomatic patients were unable to be isolated. Data was 21 
extracted by one author (BP) on to pre-piloted data forms. Authors were contacted for 22 
missing data.  23 
 24 
Risk of Bias 25 
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Risk of bias of the included studies was assessed using the Cochrane Collaboration's tool for 1 
assessing risk of bias. Eight domains of potential bias were assessed (Supplementary Table 2 
1): including sequence generation; allocation concealment; blinding of participants and 3 
personnel; blinding of outcome assessors; complete outcome data; free of selective outcome 4 
reporting, baseline similarity and ITT data analyses. Scores were summed across all 8 5 
domains to give a total score of risk bias for each study, with a possible range of 1–8. Studies 6 
with a higher score were deemed to be of higher quality, and therefore lower risk of bias. 7 
However, rather than focusing on just the scores, the quality of each study was assessed by 8 
whether or not points were given for individual quality criterion. With randomisation already 9 
being a necessary criterion, studies that have points allocated for randomised sequence 10 
generation, allocation concealment, blinding of participants, blinding of outcome assessors, 11 
and intention to treat analysis and were free of any other bias were deemed higher quality and 12 
therefore lower risk of bias. 13 
 14 
Data Extraction 15 
Walking distances analysed were the mean difference (MD) between pre- and post-group 16 
data which was calculated by subtracting baseline from post values for both the control and 17 
intervention groups. Data required was the individual group sample size, mean change and 18 
standard deviation (SD) or 95% confidence interval of the change score and/or within group 19 
p-value. When the confidence interval or SD was not available actual p-values for pre/post 20 
intervention change were used. If only the level of significance was available, we used 21 
default p-values where p<0.05 becomes p=0.049, p<0.001 becomes p=0.0099 and p=not 22 
significant becomes p=0.051. Values were taken from baseline measures, and then at the 23 
time-point closest to the end of the intervention period. For studies that contributed multiple 24 
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comparisons (e.g., one control group and two interventions groups(41)), the control group 1 
data were evenly divided into two smaller groups.  2 
 3 
Data Synthesis 4 
A narrative synthesis regarding participant characteristics and study interventions was 5 
completed. Aggregate data were used in the analyses. Mean difference (MD) and 95% 6 
Confidence Interval (CI) was calculated for the 6-MWT measures (reported in meters) and to 7 
account for any differences in testing protocols, SMD and 95% CI was calculated for the 8 
treadmill WD using the Cochrane RevMan calculator(42) in Revman version 5.3 (Nordic 9 
Cochrane Centre, Denmark). MD was unable to be calculated for constant and progressive 10 
load treadmill protocols due to the difference in protocols used across trials (i.e., some 11 
constant load protocols ran at different speeds and/or grades to other constant load protocols, 12 
and vice versa for progressive grade protocols). If enough data were provided then a 13 
quantitative synthesis was completed on each of the outcomes using an inverse variance, 14 
random effects analysis. Both statistical and clinical meaningfulness of outcomes were 15 
characterized. Statistical significance of SMDs was inferred if the CIs did not cross zero. 16 
Clinical meaningfulness of the MDs were interpreted such that a 50 m improvement in 6-17 
MWT distance was considered to be the lower threshold of a clinically important difference 18 
in this cohort(43), as this improvement is associated with a reduction in cardiovascular 19 
mortality.  20 
 21 
Moderator Analysis 22 
The significance of any heterogeneity identified was examined using the Cochran’s Q (χ²) 23 
test with p<0.05 indicating significant heterogeneity. Interpretation of heterogeneity was 24 
based on Cochrane recommendations(41) using Higgins I², with scores ranging from 0 to 25 
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100%. A cut-off of 40% was used to proceed to moderator analysis if 3 or more studies were 1 
present to help identify sources of heterogeneity in the overall meta-analysis. Moderators 2 
assessed included age, ankle brachial index, frequency, intensity, RT method, number and 3 
area of exercises, total repetitions, program length, progression and study quality. Univariate 4 
meta-regression analyses were used to assess the influence of continuous variables such as 5 
frequency, length of intervention, duration of session on walking ability. Meta-anova was 6 
completed on categorical variables such as intensity or location of training. Meta-7 
regression/anova analyses were completed with a random intercept, fixed slopes model using 8 
“Wilson’s SPSS macro(44)” and SPSS Statistics for Windows, Version 24.0 (IBM Corp, 9 
Armonk, New York, USA). For studies where both a graded treadmill protocol and constant 10 
grade protocol and below knee and above knee strength were completed and reported, effect 11 
sizes and study weighting were averaged, so both outcomes were represented in the meta 12 
regression analysis. If inconsistency remained, it was decided that the random effects model 13 
used accounted for any other differences between studies. 14 
 15 
Reporting Bias 16 
If, as according to Cochrane more than 10 studies were included in an outcome analysis, 17 
funnel plot symmetry was used to detect reporting bias(41). Funnel plots are provided in 18 
supplementary file. 19 
  20 
Results 21 
Included studies 22 
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Overall, 18 studies met the inclusion criteria for this analysis(22, 24-28, 45-56). Fourteen 1 
studies compared RT to a control group of usual medical care.  Seven studies compared RT 2 
to an aerobic exercise group(22, 24, 25, 27, 47, 48, 55), 3 of these also had a control 3 
group(24, 25, 27).  Seventeen studies published or provided enough data to be included in the 4 
quantitative analysis, Figure 1. Study quality and risk of bias is outlined in Supplementary 5 
Table 1. On average, study quality was moderate, with most trials failing to blind outcome 6 
assessors in the trials potentially leading to a detection bias, where there could be a difference 7 
between groups in how outcomes are determined. 8 
  9 
Participant Characteristics 10 
In total 826 participants were studied, with 363 completing a RT intervention. Mean age was 11 
67.1±3.8 years, range 61 to 74, and on average 68% of participants studied were male. Mean 12 
ankle brachial index was 0.66±0.23, range 0.54 to 0.75. Cardiovascular risk factors such as 13 
body mass index, waist circumference and blood pressure were poorly reported across 14 
studies. 15 
 16 
Intervention Characteristics 17 
Characteristics of the RT interventions are outlined in Table 1. Program length varied from 6 18 
to 24 weeks, (18±7 weeks).  Average training frequency was 3 times per week. Six trials 19 
trained participants twice a week(22, 47, 49, 50, 54, 55), one trial four times a week(45) and 20 
one trial daily(53).  Intensity ranged from light (30% 1RM)(26) to high at 80% 1RM(26, 57) 21 
and the number of different exercises performed ranged from 1 to 14 (7±4 exercises), while 22 
the number of sets for each type of exercises ranged from 1 to 3, when reported, with the 23 
most common number being 3. The number of repetitions per set when reported ranged from 24 
11 
 
6 to 15 (10±5 reps). Exercises involved the use of arms, legs and trunk in six studies(22, 26, 1 
28, 48-50), the upper limb only in one study(27) and the lower limb in the remainder of 2 
studies(24, 25, 45-47, 51-56). One study focussed only on the calf muscles, using 3 
plantarflexion as the chosen exercise(56).  Nine trials reported using a circuit training 4 
protocol(45, 46, 49-54, 56), while the remaining studies(22, 24-28, 47, 48, 55) had 5 
participants complete 1-3 sets of 3 to 14 reps of dynamic exercise, with 2-3 minute rests 6 
intervals between sets. Duration of exercise sessions ranged from 20 through to 60 minutes. 7 
Ten trials(22, 24-28, 47, 48, 53, 55) reported that the RT was progressed weekly during the 8 
exercise sessions; in the remaining trials progression was not reported. Out of the 18 trials, 9 
8(22, 24-28, 48, 55) reported that RT did not produce claudication pain, 8 trials(26, 46, 47, 10 
51-53) reported mild pain and 2 trials(49, 50) reported moderate pain.  11 
  12 
The Effect of RT vs. Control/Usual Care Condition 13 
Claudication Onset Distance (COD) 14 
In the eight studies(26, 46, 49, 50, 52-54, 56) measuring this outcome RT lead to a significant 15 
improvement in COD on a constant grade treadmill protocol; SMD 0.64 [0.38, 0.90]; 16 
P<0.00001, with zero heterogeneity I2=0%; p=0.57, Figure 2a.  17 
In the five studies(24-28, 46) measuring this outcome (across 6 interventions), RT lead to a 18 
significant improvement in COD on a progressive grade treadmill protocol; SMD 0.81 [0.09, 19 
1.52]; p=0.03, however, heterogeneity was substantial at I2=61%; p=0.02, Figure 2b. When 20 
only machine-based training studies (free weights excluded) were analysed, heterogeneity 21 
was reduced; I2=42%; p=0.14; however the pooled effect was no longer significant SMD 22 
0.53[-0.07, 1.13]; p=0.08.  23 
12 
 
 1 
In the three studies(26-28, 46) that measured it, (across 4 interventions), RT lead to a 2 
clinically meaningful improvement in COD during the 6-minute walk; MD 82.23m [40.91, 3 
123.54]; p<0.0001, with zero heterogeneity I2=0%; p=0.46, Figure 2c.  4 
 5 
Total Walking Distance (WD) 6 
Nine studies completed a constant grade treadmill protocol(26, 45, 46, 49, 50, 52-54, 56) 7 
(across 10 interventions). In the studies that measured it, RT lead to a significant 8 
improvement in WD in this protocol; SMD 0.48 [0.18, 0.78]; p=0.002, with minimal 9 
heterogeneity I2=33%; p=0.14, Figure 3a.  10 
 11 
Five studies(24-28) used a progressive grade treadmill protocol. In these studies, RT lead to a 12 
significant improvement in total WD; SMD 0.46 [0.09, 0.82]; p=0.01, with zero 13 
heterogeneity I2=0%; p=0.66, Figure 3b.  14 
 15 
In the four studies that measured 6-minute walk (across five interventions)(25-28) RT did not 16 
significantly improve WD; MD 25.56m [-3.12, 54.24], p=0.08; and there was minimal 17 
heterogeneity across studies I2=34%; p=0.19, Figure 3c.  18 
 19 
The Effect of Resistance Training compared to Walking Training 20 
13 
 
Five studies(22, 24, 25, 48, 55) compared RT to supervised treadmill walking training. There 1 
were only 2 studies(47, 55) that reported claudication onset during the 6-MWT; therefore, 2 
these data were unable to be combined and analysed. For 6-MWT distance, 4 studies reported 3 
enough data to be included in the analysis.  Treadmill walking training was significantly 4 
better than RT, however this difference was not clinically meaningful; MD -16.04m [-27.48, -5 
4.60], p=0.006; I2=0%, p=0.68; Figure 4a.  6 
Five studies reported enough data to analyse progressive treadmill COD.  Treadmill walking 7 
training was significantly better than RT; SMD -0.47 [-0.85, -0.08], p=0.02; Figure 4b. 8 
Notably, heterogeneity was moderate and significant at I2=59%, p=0.04. However, when high 9 
intensity studies alone were analysed, the difference between walking distances for treadmill 10 
COD was no longer significant and heterogeneity reduced substantially: progressive treadmill 11 
COD; SMD -0.30 [-0.68, 0.07], p=0.11; I2=13%, p=0.32; Figure 4c. 12 
Five studies reported enough data to analyse progressive treadmill total WD.  Treadmill 13 
walking training was not significantly better than RT; SMD -0.38 [-0.80, 0.04], p=0.07; 14 
Figure 4d). However, heterogeneity was again moderate at I2=66%, p=0.02. When moderate-15 
to-high intensity studies only were analysed, there was still no significant difference between 16 
treadmill training and RT, but heterogeneity was eliminated; SMD -0.27 [-0.60, 0.06], 17 
p=0.10; I2=0%, p=0.60; Figure 4e. As there were only 3 studies, this result warrants further 18 
exploration.  19 
 20 
Moderator Analysis for Identifying Optimal Exercise Prescriptive Elements  21 
The Effect of Intensity of RT 22 
14 
 
Random effects meta-anova results indicate that higher intensity RT leads to greater 1 
improvements in total WD (ẞ=0.53; p=0.03; low intensity (n=5) mean effect size (ES)=-0.21 2 
[-0.74, 0.29]; moderate intensity (n=6) ES=0.46 [-0.25, 0.67]; and high intensity (n=2) 3 
ES=0.66 [0.24, 1.07]; with between group p=0.02).  4 
 5 
The Effect of Muscle Groups Trained 6 
Random effects meta-anova results indicate that lower body RT leads to a greater 7 
improvement in total WD (lower body mean ES=0.67; whole body mean ES=0.39. However, 8 
the between group difference was not significant p=0.09).  9 
 10 
No statistically significant relationships with any other prescriptive elements or participant 11 
characteristics were identified. 12 
 13 
Muscle Strength Testing 14 
Although ten studies(24-28, 47, 48, 55, 57) reported muscle strength as an outcome, only 15 
four(24-26, 28) reported enough information to be included in the analysis. All four studies 16 
used a version of repetition maximum (RM) testing. Two studies(25, 26) completed a 1RM 17 
with no adverse events, one study(24) completed a 5RM on the calf muscles only and the last 18 
study completed a 10RM. Overall RT improved muscle strength with a small ES; SMD 0.43 19 
[0.16, 0.70]; p=0.002, with zero heterogeneity; I2=0%, p=0.65; Figure 5. Strength improved 20 
more robustly in the upper leg/above knee muscles of the claudicants, where a moderate ES 21 
15 
 
was noted; SMD 0.71 [0.29, 1.13], p=0.0009; and results were similar across trials; I2=0%, 1 
p=0.70. 2 
 3 
Risk of Publication Bias 4 
The number of trials reaching 10 only occurred in two outcomes; constant grade treadmill 5 
total WD and change in overall muscle strength. Funnel plots for each of the analyses are 6 
presented in Figure 1 and Figure 2 of the Supplementary material. Funnel plots are 7 
symmetrical and do not indicate publication bias for either outcome.  8 
 9 
Discussion 10 
Patients with PAD have reduced leg strength and function(22, 26).  This study has shown that 11 
RT improves leg strength and both flat ground and graded walking distances in persons with 12 
PAD. Furthermore, supervised RT programs can also improve each of the individual risk 13 
factors for cardiovascular disease in older healthy adults(58),  Trials of RT in persons with 14 
PAD therefore warrant further research to identify whether different prescriptions (i.e. 15 
adjusting frequency and intensity) may be more effective in individual patients with PAD 16 
with varied cardiovascular risk profiles.    17 
 18 
Effects of RT on walking capacity 19 
This analysis has shown that RT alone improves walking ability for persons with PAD. The 20 
mechanisms underlying these effects have been explored in few studies. RT increases muscle 21 
mass(28) and muscle strength(22, 26), measures that are already reduced in patients with 22 
PAD(21). This meta-analysis included studies showing a strong association between the 23 
16 
 
changes in strength levels and the changes in walking capacity after RT(22, 26), suggesting 1 
that strength gains leads to lowers muscle fibre recruitment during walking, thereby reducing 2 
the energy cost of walking. However, as only 4 studies included in this analysis reported 3 
strength testing results, it was difficult to explore this relationship.  4 
 5 
Walking exercise has been recommended as the primary mode of exercise for patients with 6 
PAD. Therefore, the comparison of walking exercise against RT is useful to understand the 7 
effects of RT compared to this gold-standard mode of exercise for PAD patients. This meta-8 
analysis indicated superior effects of walking exercises compared to RT. However, when sub-9 
group analyses were conducted, high intensity RT produced similar increases in walking 10 
capacity assessed during a maximal graded treadmill test compared to walking training. 11 
Although we could not compare the effects of RT against walking training during the 6-12 
MWT because there were too few studies, the similar effects of high intensity RT compared 13 
to walking training assessed during graded treadmill tests, suggest that high intensity RT may 14 
be a feasible alternative therapy to walking for patients with PAD. This could help improve 15 
adherence of exercise programs, given that patients have reported RT as being less painful 16 
than walking training(22).   17 
 18 
Elements of the most effective RT interventions and recommendations for future research 19 
When we examined which elements of interventions were associated with large, significant 20 
improvements in walking ability, high intensity RT of the lower body was the most effective 21 
element. Exercises focussing on the lower body: calf muscles, quadriceps, hamstrings and 22 
gluteals were included in the interventions with the larger effects. Further comparisons of RT 23 
intensity would be better verified with direct comparisons [i.e. moderate 60% 1RM versus 24 
high intensity (80% 1RM] within trials.  Only one study has done this to date(26), results of 25 
17 
 
which showed the ineffectiveness of low intensity (30% 1RM) training against the efficacy of 1 
high intensity (80% 1RM). Other elements of exercise prescription such as frequency of 2 
training sessions, length of program, and whether whole body exercises are more beneficial 3 
than lower limb only, remain unclear and need to be tested explicitly.  4 
 5 
Limitations  6 
Though poorly reported, some studies showed that the changes in walking distance were 7 
associated with changes in above knee leg strength(22, 26). The lack of strength testing of 8 
participants and/or lack of reporting testing results in the included trials is a major limitation 9 
of this literature.  Future trials should ensure baseline strength measures are completed prior 10 
to commencement of strength training in order to ensure appropriate overload and 11 
progression is consistently applied to the training muscles. Furthermore, trials should report 12 
both the baseline and follow up strength test results for individual muscle groups, along with 13 
changes in walking distances so the relationship between leg strength and walking distance 14 
can be explored further in future meta-analyses.  15 
 16 
As cardiovascular risk is increased in this cohort, future trials should also report the effect of 17 
the exercise training on cardiovascular risk factors such as body mass index, waist 18 
circumference, arterial stiffness, inflammation, and blood pressure. Research should also 19 
include more women and culturally and linguistically diverse cohorts. Outcomes should 20 
including measures of quality of life and physical function such as balance, chair stand, gait 21 
speed and stair climb power, in order to identify RT prescriptions that are most efficacious at 22 
improving performance of activities of daily living. Finally, studies need to report and 23 
investigate more prescriptive elements of strength training including the number of exercises, 24 
18 
 
intensity and frequency of exercise training, and conduct longer follow up testing in an effort 1 
to identify how long the effects of RT are maintained.   2 
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Figure Legend 1 
Figure 1: PRISMA Flow chart for study identification. N= number; RT= Resistance training; 2 
RCT= Randomised controlled trial; PAD= Peripheral artery disease. 3 
Figure 2: Claudication Onset Distance for (A) Constant grade treadmill protocol; (B) 4 
Progressive grade treadmill protocol; and (C) 6-minute walk. SD= Standard deviation, CI= 5 
Confidence interval, RT= Resistance training, INR= Intensity not reported, Mod=Moderate. 6 
Figure 3: Total Walking Distance for (A) Constant grade treadmill protocol; (B) Progressive 7 
grade treadmill protocol; and (C) 6-minute walk. SD= Standard deviation, CI= Confidence 8 
interval, RT= Resistance training, INR= Intensity not reported, Mod=Moderate. 9 
Figure 4: (A) 6-MWT distance for RT vs Trd training trials; (B) Progressive treadmill COD 10 
RT vs Trd training; (C) Progressive treadmill COD Mod-High Intensity RT vs Trd training; 11 
(D) Progressive treadmill total WD RT vs Trd training; (E) Progressive treadmill total WD 12 
Mod-High Intensity RT vs Trd training. SD= Standard deviation, CI= Confidence interval, 13 
RT= Resistance training, Mod=Moderate, RT= Resistance training; Trd= Treadmill; COD= 14 
Claudication onset distance; WD= Walking distance. 15 
Figure 5: Change in muscle strength across studies measuring 2.1.1 Below knee muscle 16 
strength; 2.1.2 Above knee muscle strength; and 2.1.3 Whole body muscle strength. SD= 17 
Standard deviation, CI= Confidence interval, RT= Resistance training, INR= Intensity not 18 
reported, Mod=Moderate. 19 
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Table 1 Intervention Characteristics 
      Strength Training Intervention Characteristics 
Author Group 
(n) 
Sample 
size 
(n) 
Sex 
(% 
male) 
Age 
(yrs) 
ABI RT method 
and Type of 
Resistance 
Freq 
(per 
week) 
Session 
length 
(mins) 
Intensity* 
 
N of 
ex 
Area 
of ex 
N of 
sets or 
ex:rest 
ratio 
N of 
reps/set 
Prog 
length 
(wks) 
Strength training versus usual care control 
Cheetham 
2004 
ST 
Con 
29 
30 
73 67 0.69 Dynamic 
Circuit BW 
4 28 Self-paced 7 LB 2:2 mins 24 
Dahloff 
1974 
ST 
Con 
10 
8 
72 61 NR Dynamic 
Circuit BW 
3 30 NR NR LB NR NR 24 
Hobbs 2006 ST 
Con 
7 
7 
71 72 0.70 Dynamic 
circuit BW 
2 60 Mod 11 WB 3:2 mins 12 
Hobbs 2007 ST 
Con 
9 
9 
72 67 0.75 Dynamic 
circuit BW 
2 60 Mod 11 WB 3:2 mins 12 
Holm 1973 ST 
Con 
6 
6 
NR 63 NR Dynamic 
circuit BW 
3 30 NR NR LB NR NR 24 
Lundgren 
1989 
ST 
Con 
25 
25 
NR 64 0.57 Dynamic 
circuit BW 
3 30 NR NR LB NR NR 24 
Mannarino 
1991 
ST 
Con 
10 
10 
67 63 0.67 Dynamic 
circuit BW 
7 60 NR 6 LB NR NR 24 
Stewart 
2008 
ST 
Con 
30 
30 
70 68 0.67 Dynamic 
circuit BW 
2 40 NR 5 LB NR NR 12 
Tebbut 
2010 
ST 
Con 
18 
24 
67 69 0.69 Dynamic 
Plantar-
flexion M 
1 20 Light–
mod 
1 Calf 2:2 mins 12 
Hiatt 1994 ST 
Con 
9 
10 
100 67 0.56 
 
Dynamic 
FW 
3 NR Mod 5 LB 3 6 12 
McDermott 
2009 
ST 
Con 
52 
40 
48 70 0.61 
Dynamic M 
3 NR Mod 5 LB 3 8 24 
25 
 
McGuigan 
2010 
ST 
Con 
11 
9 
46 70 0.64 Dynamic 
M/FW/BW 
3 NR Mod-High 8 WB 3 8 24 
Parmenter 
2013 
ST 1 
ST 2 
Con 
7 
7 
7 
64 73 0.54 
Dynamic M 
3 60 Light 
High 
7 WB 3 8 24 
Parr 2009 ST 
Con 
9 
8 
68 62 NR Dynamic 
M/FW 
3 NR Mod 14 UB 1 15 6 
Strength training versus other exercise 
Delaney 
2014 
ST 17 77 69 0.72 Dynamic M 
2 
60 Light 6 LB 3 8 to 12 
12 
Alt Ex 18 67 73 0.71 Trd walk 60 Self-paced   Max pain:rest 
Gardner 
2014 
ST 60 60 65 0.74 Dynamic M 
3 
NR Light 9 WB 1 15 
12 Alt Ex 60 52 67 0.68 Home walk 20 ↑ - 45 Self-paced   
Mild-Mod pain:rest 
Alt Ex 60 48 65 0.68 Trd walk 15 ↑ - 40 40% peak   
Hiatt 1994 
ST See above 
Alt Ex 10 100 67 0.55 Trd walk 3 60 Self-paced   Mod pain:rest 12 
McDermott 
2009 
ST See above 
Alt Ex 51 47 72 0.60 Trd walk 3 15 ↑ - 40 Mod   Mod-max pain:rest 24 
Ritti-Dias 
2010 
ST 15 60 66 0.63 Dynamic M 
2 60 Mod 
8 WB 3 10 
12 
Alt Ex 15 73 65 0.66 Trd walk   2:2 mins mild pain 
Szymczak 
2016 
ST 26 
NR NR 0.67 
Dynamic M 
2 50 
Light-mod 6 LB 3 15 
12 
Alt Ex 24 Trd walk Self-paced   Mild pain 
N= number; ST= strength training; Ex= exercise; Freq= frequency; Mins= minutes; Con= control; RT= resistance training; RM= 
repetition maximum; LB= lower body; UB= upper body; WB= whole body; BW= body weight; M= machine based training; FW= 
free weights; NR= not reported; Mod= moderate; Vig= vigorous; Alt Ex= Alternate exercise; Vol*= volume (sets x repetitions x 
days); Prog= progression;  
* According to American College of Sports Medicine; 
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